HR 5663
117th Congress
House
Health
Cardiovascular and respiratory health
Drug therapy
Emergency medical services and trauma care
Health care coverage and access
Health facilities and institutions
Health technology, devices, supplies
Immunology and vaccination
Infectious and parasitic diseases
State and local government operations
TREAT Act
Introduced: October 21, 2021
Introduced by:
Harshbarger, Diana
Republican
· Tennessee
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 22, 2021
Referred to the Subcommittee on Health.
Oct 21, 2021
Referred to the House Committee on Energy and Commerce.
Oct 21, 2021
Introduced in House
Plain-English summary
Treatment Restoration for Emergency Antibody Therapeutics Act or the TREAT Act
This bill prohibits the Department of Health and Human Services (HHS) from implementing any policy that restricts health care facilities from ordering and receiving COVID-19 monoclonal antibody therapies directly from manufacturers and distributors. In addition, the bill expressly nullifies a policy announced on September 13, 2021, under which HHS allocated supplies of these therapies through state or territorial governments.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2